Vector-Borne Disease National Strategy

As mandated by the Kay Hagan Tick Act, signed into law in 2019 as part of the FY 2020 Further Consolidated Appropriations Act, OASH is working closely with CDC to develop a National Strategy to address Vector-Borne Diseases carried by ticks and other blood-feeding vectors. 

The National Strategy will identify:

  • gaps and unnecessary duplication in federally funded programs
  • strategic goals to address vector-borne diseases
  • benchmarks to measure progress toward achieving such goals

OASH and CDC are co-leading the interagency development of the National Strategy in consultation with the Tick-Borne Disease Working Group. To deliver the National Strategy to Congress by December 2023, HHS has published two requests for information (RFIs) for public input to help the U.S. government develop its strategy:

OPEN NOW! Please submit your RFI comments on before 12:00pm midnight Eastern Time (ET) on December 21, 2022.

  • Request for Information (RFI): Developing the National Public Health Strategy for the Prevention and Control of Vector-Borne Diseases in Humans. Federal Register notice by the Health and Human Services Department. Publication date: 04/27/2021. Comments closed 6/11/2021.

The National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans (CDC, 2020) lays a foundation for developing and executing a full National Strategy that details the activities needed to accomplish the articulated goals.

Questions? Please email

Content created by Assistant Secretary for Health (ASH)
Content last reviewed